The role of functional polymorphisms of the TNF-α gene promoter in the risk of ischemic stroke in Chinese Han and Uyghur populations: Two case-control studies

Clinica Chimica Acta

Volumn 411, Issue 17-18, 2010, Pages 1291-1295

  Tong, Yeqing ^a,c   Geng, Yijie ^b   Xu, Jing ^a   Wang, Zhihong ^c   Zhang, Yanwei ^b   Lin, Liangqiang ^b   Zhang, Renli ^b   Deng, Pingjian ^b   Li, Yongbin ^a   Hou, Wanli ^a   Chai, Yun ^a   Mason, Katherine A ^d   Lu, Zuxun ^a,c   Cheng, Jinquan ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Shenzhen Center for Chronic Disease Control   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Ethnic populations; Functional polymorphisms; Ischemic stroke; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; PRIMER DNA;

ADULT; ARTICLE; BRAIN ISCHEMIA; CHINESE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROMOTER REGION; AGED; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CHINA; ETHNIC GROUP; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE;

AGED; BASE SEQUENCE; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CHINA; DNA PRIMERS; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; STROKE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954143096     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.05.007     Document Type: Article

References (42)

1. Humphries S.E., Morgan L. Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol 2004, 3:227-235.
2. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol 2007, 6:149-161.
3. Bova I.Y., Bornstein N.M., Korczyn A.D. Acute infection as a risk factor for ischemic stroke. Stroke 1996, 27:2204-2206.
4. Grau A.J., Buggle F., Becher H., et al. Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies. Neurology 1998, 50:196-203.
5. Macko R.F., Ameriso S.F., Barndt R., Clough W., Weiner J.M., Fisher M. Precipitants of brain infarction. Roles of preceding infection/inflammation and recent psychological stress. Stroke 1996, 27:1999-2004.
6. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
7. Hoppe C., Klitz W., D'Harlingue K., et al. Confirmation of an association between the TNF(-308) promoter polymorphism and stroke risk in children with sickle cell anemia. Stroke 2007, 38:2241-2246.
8. Um J.Y., Lee J.H., Joo J.C., et al. Association between tumor necrosis factor-alpha gene polymorphism and Sasang constitution in cerebral infarction. Am J Chin Med 2005, 33:547-557.
9. Lee Y.B., Nagai A., Kim S.U. Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res 2002, 69:94-103.
10. Hashimoto T., Wen G., Lawton M.T., et al. Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke 2003, 34:925-931.
11. Nijboer C.H., Heijnen C.J., Groenendaal F., van Bel F., Kavelaars A. Alternate pathways preserve tumor necrosis factor-alpha production after nuclear factor-kappaB inhibition in neonatal cerebral hypoxia-ischemia. Stroke 2009, 40:3362-3368.
12. Tuttolomondo A., Di Sciacca R., Di Raimondo D., et al. Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site. J Neuroimmunol 2009, 215:84-89.
13. Reich K., Mossner R., Konig I.R., Westphal G., Ziegler A., Neumann C. Promoter polymorphisms of the genes encoding tumor necrosis factor-alpha and interleukin-1beta are associated with different subtypes of psoriasis characterized by early and late disease onset. J Investig Dermatol 2002, 118:155-163.
14. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195-3199.
15. Wood P.H. Appreciating the consequences of disease: the international classification of impairments, disabilities, and handicaps. WHO Chron 1980, 34:376-380.
16. Adams H.P., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
17. Bamford J., Sandercock P., Dennis M., Burn J., Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991, 337:1521-1526.
18. Humphries S.E., Morgan L. Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol 2004, 3:227-235.
19. Bak S., Gaist D., Sindrup S.H., Skytthe A., Christensen K. Genetic liability in stroke: a long-term follow-up study of Danish twins. Stroke 2002, 33:769-774.
20. Liao D., Myers R., Hunt S., et al. Familial history of stroke and stroke risk. The Family Heart Study. Stroke 1997, 28:1908-1912.
21. Jousilahti P., Rastenyte D., Tuomilehto J., Sarti C., Vartiainen E. Parental history of cardiovascular disease and risk of stroke. A prospective follow-up of 14371 middle-aged men and women in Finland. Stroke 1997, 28:1361-1366.
22. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol 2007, 6:149-161.
23. Han S.H., Liu J.P., Tan A., et al. Association of platelet-derived growth factor-D gene polymorphism with ischemic stroke in a Chinese case-control study. Blood Coagul Fibrinolysis 2008, 19:415-419.
24. Cheng J., Liu J., Li X., et al. Insulin-like growth factor-1 receptor polymorphism and ischemic stroke: a case-control study in Chinese population. Acta Neurol Scand 2008, 118:333-338.
25. Cheng J., Liu J., Li X., et al. Effect of polymorphisms of endothelial nitric oxide synthase on ischemic stroke: a case-control study in a Chinese population. Clin Chim Acta 2008, 392:46-51.
26. Liu J., Cheng J., Peng J., Han S., Yu L., Nie S. Effects of polymorphisms of heat shock protein 70 gene on ischemic stroke, and interaction with smoking in China. Clin Chim Acta 2007, 384:64-68.
27. Tong, Y., Wang, Z., Geng, Y., et al. The association of functional polymorphisms of IL-6 gene promoter with ischemic stroke: analysis in two Chinese populations. Biochem Biophys Res Commun 2010;391:481-5.
28. Kouwenhoven M., Carlstrom C., Ozenci V., Link H. Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke. J Clin Immunol 2001, 21:365-375.
29. Chao C.C., Hu S., Ehrlich L., Peterson P.K. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 1995, 9:355-365.
30. Benveniste E.N. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992, 263(C1-16).
31. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995, 26:676-681.
32. Bruce A.J., Boling W., Kindy M.S., et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 1996, 2:788-794.
33. Castillo J., Moro M.A., Blanco M., et al. The release of tumor necrosis factor-alpha is associated with ischemic tolerance in human stroke. Ann Neurol 2003, 54:811-819.
34. Kroeger K.M., Carville K.S., Abraham L.J. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997, 34:391-399.
35. Bouma G., Xia B., Crusius J.B., et al. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 1996, 103:391-396.
36. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195-3199.
37. Vogelgesang, A., May, V.E., Grunwald, U., et al. Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS One; 5:e8718.
38. Grove J., Daly A.K., Bassendine M.F., Day C.P. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997, 26:143-146.
39. Um J.Y., An N.H., Kim H.M. TNF-αlpha and TNF-beta gene polymorphisms in cerebral infarction. J Mol Neurosci 2003, 21:167-171.
40. Um J.Y., Kim H.M. Tumor necrosis factor alpha gene polymorphism is associated with cerebral infarction. Brain Res Mol Brain Res 2004, 122:99-102.
41. Shi K.L., He B., Wang J.J., Zou L.P. Role of TNF-αlpha gene variation in idiopathic childhood ischemic stroke: a case-control study. J Child Neurol 2009, 24:25-29.
42. Xu J, Wu N, Jin S, et al. Analysis of inpatient bed allocation equity and utilization in the city community health service center of China. J Huazhong Univ Sci Technolog Med Sci; 30:141-144.